United States · FDA National Drug Code directory
Bupropion Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50268-134_2f9c516e-9c18-af30-e063-6394a90a4a70
- Product NDC
- 50268-134
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Bupropion Hydrochloride
- Labeler
- AvPAK
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250305
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 BLISTER PACK in 1 BOX (50268-134-13) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-134-11) · 50268-134-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →